Phase I oncology trials play a crucial role in drug development, yet they are extremely challenging for sites. To discuss this in greater detail, we’re joined by Dan Otap, principal, alliance and partnerships lead at Genentech, and Jenn Weinberg, a veteran in oncology clinical trials. During the podcast, they delve into why early-stage oncology trials are so complex and ways to ease the burden on sites.
“There's a level of safety and concern and risk that separates and creates a very distinct space when you're talking about early phase oncology. The fact that these patients that become brave participants on these trials are immunocompromised, severely sick, heavily pre-treated – you have a scenario fraught with potential complications.”
As Dan discusses in the podcast, the Society for Clinical Research (SCRS) has recently launched a white paper on best practices to build out Phase I units in institutions.
Popular Podcasts
Las Culturistas with Matt Rogers and Bowen Yang
Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.